Q32 Bio Operations, Inc

Q32 Bio Inc., located in Waltham, MA, is focused on the development of targeted immune therapeutics aimed at transforming the lives of patients with alopecia areata and other autoimmune and inflammatory diseases. The company is comprised of a skilled team of scientists, immunologists, and drug developers dedicated to rebalancing the immune system through innovative therapies. The company's lead product candidate, Bempikibart, is a fully human monoclonal antibody designed to block interleukin-7 receptor alpha signaling, thereby re-regulating adaptive immune function. Currently, Bempikibart is undergoing evaluation in a Phase 2 clinical trial for patients with alopecia areata. Generated from the website

Arrakis Therapeutics is a biotechnology company located in Waltham, MA, focused on developing innovative therapies through its proprietary rSM platform. The company is dedicated to advancing its pipeline and engaging with the scientific community through publications and initiatives like the Dark Matter Blog. With a commitment to transforming drug discovery, Arrakis Therapeutics aims to address unmet medical needs and contribute to the future of healthcare. The company fosters a dynamic work environment, as highlighted by its insights into life on Arrakis and current career opportunities. Generated from the website

Zenas Biopharma, Inc., located in Waltham, MA, is a dedicated team focused on developing therapies for autoimmune diseases, aiming to address significant unmet patient needs and transform lives. Their investigational drug, Obexelimab, is a bi-functional monoclonal antibody designed to suppress B cell activity, which plays a key role in many autoimmune conditions. The company is committed to understanding patient experiences and introducing transformative therapies that help individuals realize the lives they intended. With a strong emphasis on leadership in the development and commercialization of these therapies, Zenas Biopharma strives to advance its programs across multiple autoimmune diseases. Generated from the website